There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same. The polymeric forms include crystalline treprostinil monohydrate Form A, crystalline treprostinil monohydrate Form B, and treprostinil Form C. The methods of preparation of such forms, their characterization by differential scanning calorimetry (DSC) is provided.
